Treatment Of Patients With Rare Diseases And Requiring Permanent Replacement Therapy (27 03 03 06) _ Tocilizumab 162 Mg Ready-To-Use Syringe (Funding Will Be Implemented Within The Framework Of The Appropriations Approved By The 2025 State Budget).

სსიპ ჯანმრთელობის ეროვნული სააგენტო Georgia has Released a tender for Treatment Of Patients With Rare Diseases And Requiring Permanent Replacement Therapy (27 03 03 06) _ Tocilizumab 162 Mg Ready-To-Use Syringe (Funding Will Be Implemented Within The Framework Of The Appropriations Approved By The 2025 State Budget). in Pharmaceuticals. The tender was released on Dec 28, 2024.

Country - Georgia

Summary - Treatment Of Patients With Rare Diseases And Requiring Permanent Replacement Therapy (27 03 03 06) _ Tocilizumab 162 Mg Ready-To-Use Syringe (Funding Will Be Implemented Within The Framework Of The Appropriations Approved By The 2025 State Budget).

Deadline - Jan 30, 2025

GT reference number - 100645657

Product classification - Pharmaceutical products